Renal monocyte chemoattractant protein-1: an emerging universal biomarker and therapeutic target for kidney diseases?

Markers of early progressive renal decline in type 2 diabetes suggest different implications for etiological studies and prognostic tests development

(2018) Natalia Nowak et al.   KIDNEY INTERNATIONAL

Mcp1 Promotes Macrophage-Dependent Cyst Expansion in Autosomal Dominant Polycystic Kidney Disease

(2018) Marcelo F. Cassini et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

OUP accepted manuscript

(2018)   NEPHROLOGY DIALYSIS TRANSPLANTATION

OUP accepted manuscript

(2018)   NEPHROLOGY DIALYSIS TRANSPLANTATION

C–C chemokine receptor type 2 mediates glomerular injury and interstitial fibrosis in focal segmental glomerulosclerosis

(2018) Anja Wilkening et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Randomized Trial of C5a Receptor Inhibitor Avacopan in ANCA-Associated Vasculitis

(2017) David R.W. Jayne et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Targeting new cellular disease pathways in autosomal dominant polycystic kidney disease

(2017) Ming-Yang Chang et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Hyperglycemia-induced Renal P2X7 Receptor Activation Enhances Diabetes-related Injury

(2017) Robert I. Menzies et al.   EBioMedicine

Association of Urinary Biomarkers of Inflammation, Injury, and Fibrosis with Renal Function Decline: The ACCORD Trial

(2016) G. N. Nadkarni et al.   Clinical Journal of the American Society of Nephrology

Autosomal dominant polycystic kidney disease: the changing face of clinical management

(2015) Albert C M Ong et al.   LANCET

Evaluation and validation of biomarkers in granulomatosis with polyangiitis and microscopic polyangiitis

(2015) Andreas Kronbichler et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

The effect of CCR2 inhibitor CCX140-B on residual albuminuria in patients with type 2 diabetes and nephropathy: a randomised trial

(2015) Dick de Zeeuw et al.   Lancet Diabetes & Endocrinology

Urinary Biomarkers in Relapsing Antineutrophil Cytoplasmic Antibody-associated Vasculitis

(2013) J. G. Lieberthal et al.   JOURNAL OF RHEUMATOLOGY

Macrophages Promote Cyst Growth in Polycystic Kidney Disease

(2011) A. Karihaloo et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Association of Urinary Biomarkers With Disease Severity in Patients With Autosomal Dominant Polycystic Kidney Disease: A Cross-sectional Analysis

(2010) Esther Meijer et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Urinary monocyte chemoattractant protein-1 (MCP-1) and connective tissue growth factor (CCN2) as prognostic markers for progression of diabetic nephropathy

(2009) Frederick W.K. Tam et al.   CYTOKINE

Effect of the Monocyte Chemoattractant Protein-1/CC Chemokine Receptor 2 System on Nephrin Expression in Streptozotocin-Treated Mice and Human Cultured Podocytes

(2009) E. Tarabra et al.   DIABETES

Monocyte Chemoattractant Protein 1 is a Prognostic Marker in ANCA-Associated Small Vessel Vasculitis

(2009) Sophie Ohlsson et al.   MEDIATORS OF INFLAMMATION

The ratio of epidermal growth factor to monocyte chemotactic peptide-1 in the urine predicts renal prognosis in IgA nephropathy

(2007) D.D. Torres et al.   KIDNEY INTERNATIONAL